Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
US-2017129950-A1 · May 11, 2017 · US
This page is not indexed by search engines while we improve data quality.
Hashimoto Eri patents
Hashimoto Eri is listed as an inventor on 4 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Hashimoto Eri |
| Total patents | 4 |
| First publication | Apr 23, 2015 |
| Latest publication | May 11, 2017 |
Notable patents
Publications ranked by popularity score, then publication date.
Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient
US-9556264-B2 · Jan 31, 2017 · US
Therapeutic Agent Comprising Humanized Anti-Epiregulin Antibody as Active Ingredient for Non-Small-Cell Lung Carcinoma Excluding Adenocarcinoma
US-2016159919-A1 · Jun 9, 2016 · US
Humanized Anti-Epiregulin Antibody, and Cancer Therapeutic Agent Comprising Said Antibody as Active Ingredient
US-2015110793-A1 · Apr 23, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Chugai Pharmaceutical Co Ltd | 4 |
| Miyagi Cancer Ct Res Inst | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 4 |
| C07K2317/24 | 4 |
| C07K2317/732 | 4 |
| C07K2317/56 | 4 |
| C07K16/22 | 4 |